What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.07%Below 5Y avg (2.07%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
53.8%Sustainable
Payback Period
91.2 yr
Last Ex-Dividend
Sep 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.83BCNY
726.77M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
16.54x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Revenue (TTM)
1.78BCNY
267.25M · vs all stocks (USD)
Updated Oct 21, 2026
Profit Margin
16.33%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Beta
0.1390x
vs all stocks
Updated Oct 21, 2026
52-Week Change
1.19%
vs all stocks
Updated Oct 21, 2026
Market Capitalization
4.83BCNY
726.77M · vs all stocks (USD)
Updated Oct 21, 2026
Enterprise Value
4.63BCNY
696.37M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing P/E
16.54x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Forward P/E
18.52x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Price to Sales (TTM)
2.72x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Price to Book (MRQ)
3.12x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Enterprise to Revenue
2.61x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Enterprise to EBITDA
9.83x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 13.31×.Updated Oct 21, 2026
Gross Margin
35.62%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Profit Margin
16.33%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Operating Margin
22.63%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Return on Assets (TTM)
7.71%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Return on Equity (TTM)
20.34%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Revenue (TTM)
1.78BCNY
267.25M · vs all stocks (USD)
Updated Oct 21, 2026
Revenue per Share (TTM)
3.42CNYUpdated Oct 21, 2026
Quarterly Revenue Growth
15.20%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Gross Profit (TTM)
637.53MCNY
95.84M · vs all stocks (USD)
Updated Oct 21, 2026
EBITDA (TTM)
348.10MCNY
52.33M · vs all stocks (USD)
Updated Oct 21, 2026
Net Income (TTM)
290.24MCNY
43.63M · vs all stocks (USD)
Updated Oct 21, 2026
Quarterly Earnings Growth (YoY)
11.90%
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Operating Cash Flow (TTM)
419.19MCNY
63.02M · vs all stocks (USD)
Updated Oct 21, 2026
Levered Free Cash Flow (TTM)
87.03MCNY
13.08M · vs all stocks (USD)
Updated Oct 21, 2026
Trailing Annual Dividend Rate
0.1002CNYUpdated Oct 21, 2026
Trailing Annual Dividend Yield
1.07%
vs all stocks
Updated Oct 21, 2026
5-Year Average Dividend Yield
2.07%
vs all stocks
Updated Oct 21, 2026
Payout Ratio
53.80%
vs Medical Instruments & Supplies peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 17.9%.Updated Oct 21, 2026
Minority Interest (Equity)
95.27MCNYFY2025 · Dec 31, 2025
Revenue
1.64BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.05BCNYFY2025 · Dec 31, 2025
Gross Profit
590.86MCNYFY2025 · Dec 31, 2025
Operating Income
326.75MCNY
49.12M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
324.24MCNYFY2025 · Dec 31, 2025
Income Tax Expense
33.97MCNYFY2025 · Dec 31, 2025
Net Income
290.27MCNYFY2025 · Dec 31, 2025
EBIT
326.06MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
458.89MCNYFY2025 · Dec 31, 2025
Research & Development
75.28MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
69.31MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
15.90MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.16MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
1.82MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.5117CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.5117CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
517.76MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
517.76MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
290.27MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-25.33MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
256.22MCNYFY2025 · Dec 31, 2025
Free Cash Flow
15.01MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
418.16MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
290.27MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.94MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-19.47MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-16.51MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-241.21MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-881.50MCNYFY2025 · Dec 31, 2025
Sale of Investments
967.35MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-155.36MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
81.34MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-69.40MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-163.29MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-1.28MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-152.63MCNYFY2025 · Dec 31, 2025
Shares Outstanding
522.08MSharesUpdated Oct 21, 2026
Float Shares
296.07MSharesUpdated Oct 21, 2026
% Held by Insiders
50.46%
vs all stocks
Updated Oct 21, 2026
% Held by Institutions
3.24%
vs all stocks
Updated Oct 21, 2026
Total Cash (MRQ)
988.94MCNY
148.67M · vs all stocks (USD)
Updated Oct 21, 2026
Total Cash per Share (MRQ)
1.90CNYUpdated Oct 21, 2026
Total Debt (MRQ)
722.75MCNY
108.65M · vs all stocks (USD)
Updated Oct 21, 2026
Total Debt to Equity (MRQ)
0.4444x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Current Ratio (MRQ)
2.07x
vs Medical Instruments & Supplies peers
Updated Oct 21, 2026
Book Value per Share (MRQ)
2.97CNYUpdated Oct 21, 2026
Total Assets
2.43BCNY
365.13M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
925.20MCNYFY2025 · Dec 31, 2025
Total Liabilities
875.32MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.50BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
265.82MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
609.51MCNYFY2025 · Dec 31, 2025
Cash
418.16MCNYFY2025 · Dec 31, 2025
Cash Equivalents
13.31MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
431.47MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
157.45MCNYFY2025 · Dec 31, 2025
Accounts Receivable
76.65MCNYFY2025 · Dec 31, 2025
Inventory
199.97MCNYFY2025 · Dec 31, 2025
Accounts Payable
394.12MCNYFY2025 · Dec 31, 2025
Short-term Debt
49.34MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.92MCNYFY2025 · Dec 31, 2025
Long-term Debt
180.69MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
461.46KCNYFY2025 · Dec 31, 2025
Common Stock (Book)
522.08MCNYFY2025 · Dec 31, 2025
Retained Earnings
735.36MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.55BCNY
233.55M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
13.15MCNYFY2025 · Dec 31, 2025
52-Week Low
8.60CNYUpdated Oct 21, 2026
52-Week High
10.78CNYUpdated Oct 21, 2026
52-Week Change
1.19%
vs all stocks
Updated Oct 21, 2026
Beta
0.1390x
vs all stocks
Updated Oct 21, 2026
50-Day MA
9.31CNYUpdated Oct 21, 2026
200-Day MA
9.51CNYUpdated Oct 21, 2026
Avg 10-Day Volume
6.02MSharesUpdated Oct 21, 2026
Avg 30-Day Volume
5.40MSharesUpdated Oct 21, 2026
Diluted EPS (TTM)
0.5600CNYUpdated Oct 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.01: safe zoneNotable
Altman Z-Score: 5.01
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.